Viewing Study NCT00637403


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-06-26 @ 5:11 AM
Study NCT ID: NCT00637403
Status: TERMINATED
Last Update Posted: 2016-10-17
First Post: 2008-03-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension
Sponsor: Par Pharmaceutical, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None renal impairment View
None end stage renal disease View
None megestrol acetate View
None pharmacokinetics View
None hemodialysis View
None renal dialysis View
None kidney failure, chronic View
None renal insufficiency View
None Megace ES View